0000904454-16-001467.txt : 20161004
0000904454-16-001467.hdr.sgml : 20161004
20161004161238
ACCESSION NUMBER: 0000904454-16-001467
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160930
FILED AS OF DATE: 20161004
DATE AS OF CHANGE: 20161004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Public Joint Stock Co Pharmstandard
CENTRAL INDEX KEY: 0001598754
STATE OF INCORPORATION: 1Z
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 161918978
BUSINESS ADDRESS:
STREET 1: LIKHACHEVSKY DRIVE
STREET 2: 5 "B"
CITY: DOLGOPRUDNY
STATE: 1Z
ZIP: 141701
BUSINESS PHONE: 7 495 970 0032
MAIL ADDRESS:
STREET 1: LIKHACHEVSKY DRIVE
STREET 2: 5 "B"
CITY: DOLGOPRUDNY
STATE: 1Z
ZIP: 141701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pharmstandard International S.A.
CENTRAL INDEX KEY: 0001598762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 161918979
BUSINESS ADDRESS:
STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1528
BUSINESS PHONE: 352 26449 557
MAIL ADDRESS:
STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1528
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-09-30
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001598762
Pharmstandard International S.A.
10A, RUE HENRY SCHNADT
LUXEMBOURG
N4
L-2530
LUXEMBOURG
0
0
1
0
0001598754
Public Joint Stock Co Pharmstandard
LIKHACEVSKY DRIVE 5 "B"
DOLGOPRUDNY
1Z
141700
RUSSIAN FEDERATION
0
0
1
0
Common Stock
2016-09-30
4
P
0
30232
4.71
A
13199567
I
See footnote
Common Stock
2016-10-03
4
P
0
11308
4.70
A
13210875
I
See footnote
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ Eriks Martinovskis, Director, Pharmstandard International S.A.
2016-10-03
/s/ Victor Fedlyuk, Deputy General Director for Legal Affairs, Public Joint Stock Company Pharmstandard
2016-10-03